Search results
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
Reuters via Yahoo Finance· 18 hours agoPfizer and BioNTech asked a London court to revoke rival Moderna's patents over technology key to...
Better Buy: Pfizer vs. Viking Therapeutics
Motley Fool via Yahoo Finance· 16 hours agoAt the same time, several big pharma companies continue to offer attractive valuations and dividend yields. Image Source: Getty Images. Pfizer (NYSE:...
Pfizer (PFE) Rises Higher Than Market: Key Facts
Zacks via Yahoo Finance· 1 day agoPfizer (PFE) closed at $26.26 in the latest trading session, marking a +1% move from the prior day. This move outpaced the S&P 500's daily gain of 0.87%....
Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown -...
Benzinga· 10 hours agoModerna Inc. MRNA is set to clash with Pfizer Inc. PFE and BioNTech SE BNTX in a pivotal London...
Moderna, Pfizer/BioNTech set for UK court clash over COVID jab patents
Medical Xpress· 21 hours agoA row between pharmaceutical firms Moderna and Pfizer/BioNTech comes to court in London on Tuesday...
Rival Covid-19 jab developers face off in High Court patent trial
PA Media: Science via Yahoo News· 17 hours agoRival developers of Covid-19 jabs have faced off at the High Court in London as a weeks-long trial...
Levi Strauss, Pfizer, Goldman Sachs and Cigna Face Challenges from Conservative Shareholders
National Center for Public Policy Research· 14 hours agoProposals Target Donations to Radical Causes, Net Zero Plans and DEI Programs Washington, D.C. – Shareholder activists with the National Center for Public Policy Research’s Free Enterprise Project ...
3 Underappreciated Pharmaceutical Stocks to Buy Before They Surge
InvestorPlace· 10 hours agoThis seems to be the case with pharmaceutical stocks. During the covid-19 pandemic, the pharma...
Sigma Planning Corp Lowers Stake in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 2 days agoSigma Planning Corp lowered its stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 52.6% in the fourth quarter, according to its most recent 13F filing with the SEC ...
Is Pfizer Stock A Sell As Shares Hit A 9-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 6 days agoPfizer stock is trading at a nine-year low as the drugmaker looks for its next big break after...